Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M222,353Revenue $M49,116Net Margin (%)18.7Altman Z-Score2.9
Enterprise Value $M230,881EPS $1.4Operating Margin %25.9Piotroski F-Score6
P/E(ttm)25.0Beneish M-Score-2.7Pre-tax Margin (%)25.4Higher ROA y-yN
Price/Book3.310-y EBITDA Growth Rate %3.0Quick Ratio2.2Cash flow > EarningsY
Price/Sales4.75-y EBITDA Growth Rate %5.0Current Ratio2.5Lower Leverage y-yN
Price/Free Cash Flow17.7y-y EBITDA Growth Rate %-14.2ROA % (ttm)5.4Higher Current Ratio y-yY
Dividend Yield %3.0PEG5.0ROE % (ttm)12.4Less Shares Outstanding y-yY
Payout Ratio %73.0Shares Outstanding M6,158ROIC % (ttm)12.1Gross Margin Increase y-yN

Gurus Latest Trades with PFE

Number of guru portfolios checked: 68.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PFEKahn Brothers 2015-06-30 Reduce-0.21%$33.46 - $35.44
($34.36)
$ 35.894%Reduce 2.00%1,774,875
PFEKen Fisher 2015-06-30 Add0.04%$33.46 - $35.44
($34.36)
$ 35.894%Add 1.95%31,816,749
PFEKahn Brothers 2015-03-31 Reduce-0.39%$31.16 - $35.05
($33.51)
$ 35.897%Reduce 3.83%1,811,016
PFEJames Barrow 2015-03-31 Reduce-0.32%$31.16 - $35.05
($33.51)
$ 35.897%Reduce 12.24%55,080,222
PFENWQ Managers 2015-03-31 Reduce-0.16%$31.16 - $35.05
($33.51)
$ 35.897%Reduce 6.64%5,927,532
PFEJoel Greenblatt 2015-03-31 Add0.15%$31.16 - $35.05
($33.51)
$ 35.897%Add 38.84%1,972,788
PFECharles Brandes 2015-03-31 Reduce-0.07%$31.16 - $35.05
($33.51)
$ 35.897%Reduce 2.37%6,123,536
PFEDavid Dreman 2015-03-31 Add0.03%$31.16 - $35.05
($33.51)
$ 35.897%Add 70.38%25,202
PFEMario Gabelli 2015-03-31 Reduce-0.01%$31.16 - $35.05
($33.51)
$ 35.897%Reduce 5.80%896,431
PFEDodge & Cox 2015-03-31 Reduce-0.01%$31.16 - $35.05
($33.51)
$ 35.897%Reduce 0.89%46,776,959
PFEKen Fisher 2015-03-31 Add$31.16 - $35.05
($33.51)
$ 35.897%Add 0.04%31,208,271
PFEFirst Eagle Investment 2015-03-31 Reduce$31.16 - $35.05
($33.51)
$ 35.897%Reduce 0.12%5,266,820
PFERichard Pzena 2015-03-31 Reduce$31.16 - $35.05
($33.51)
$ 35.897%Reduce 0.50%2,159,618
PFEJohn Keeley 2015-03-31 Reduce$31.16 - $35.05
($33.51)
$ 35.897%Reduce 1.27%98,689
PFEKahn Brothers 2014-12-31 Reduce-0.49%$27.7 - $32.09
($30.23)
$ 35.8919%Reduce 5.14%1,883,217
PFEFirst Eagle Investment 2014-12-31 Add0.39%$27.7 - $32.09
($30.23)
$ 35.8919%Add 3786.85%5,272,943
PFERichard Pzena 2014-12-31 Buy 0.36%$27.7 - $32.09
($30.23)
$ 35.8919%New holding2,170,568
PFEVanguard Health Care Fund 2014-12-31 Add0.32%$27.7 - $32.09
($30.23)
$ 35.8919%Add 29.88%19,395,622
PFEMichael Price 2014-12-31 Sold Out -0.17%$27.7 - $32.09
($30.26)
$ 35.8919%Sold Out0
PFEKahn Brothers 2014-09-30 Reduce-0.59%$28.04 - $30.96
($29.58)
$ 35.8921%Reduce 6.56%1,985,161
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PFE is held by these investors:

Premium Most recent portfolio changes are included for Premium Members only!


PFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
CANGIALOSI LORETTA VSr. Vice President, Controller 2015-07-30Sell24,704$35.651.4view
OLSON LAURIE JExecutive Vice President 2015-06-11Sell26,000$34.395.12view
HILL CHARLES HExecutive Vice President 2015-05-29Sell42,870$34.923.52view
SUSMAN SALLYExecutive Vice President 2015-03-12Sell46,179$346.32view
READ IAN CChairman & CEO 2015-03-05Sell67,500$34.624.42view
Dolsten MikaelPresident R&D 2015-03-05Sell58,298$34.464.9view
CANGIALOSI LORETTA VSr. Vice President, Controller 2015-02-13Sell104,000$34.734.09view
MADDALUNA ANTHONY JExecutive Vice President 2015-02-12Sell9,000$34.853.73view
DAMELIO FRANK AExecutive Vice President 2015-02-11Sell80,200$34.235.61view
DAMELIO FRANK AExecutive Vice President 2015-02-11Sell14,800$34.35.39view

Quarterly/Annual Reports about PFE:

    News about PFE:

    Articles On GuruFocus.com
    Pfizer Increases Annual Earnings Guidance for 2015 Jul 29 2015 
    It’s Not Too Late To Buy Gilead Sciences Jul 17 2015 
    Perrigo Company Is Strong But Overvalued Jul 15 2015 
    Despite Recent Downgrade, This Ecommerce Giant is a Buy Jun 29 2015 
    Paul Tudor Jones' Top Three Stocks Deliver Positive Returns Jun 24 2015 
    Bristol-Myers Squibb Takes A Step Up On Cancer Drugs, But The Cost Tells A Different Story Jun 22 2015 
    A Look at James Barrow's Investment in Pfizer Jun 16 2015 
    Jim Simons' Top 3 Positions and One That Doubled Return Jun 10 2015 
    Will GlaxoSmithKline Cut Its 6% Dividend? Jun 03 2015 
    Apple, SunEdison and Biogen: Hellman, Jordan Management's Top 3 Stocks Outperform the Rise in the S& May 28 2015 

    More From Other Websites
    Gilead Sciences, Inc. Earnings Analysis: By the Numbers Q2*, 2015 Aug 04 2015
    Pfizer Inc. Earnings Analysis: By the Numbers Q2*, 2015 Aug 04 2015
    Beach Bugs: Illnesses Often Follow Offshore Swims Aug 03 2015
    Large Insider Transactions at Rent-A-Center Inc. (RCII), Air Products & Chemicals Inc. (APD), and... Aug 03 2015
    S&P 500 Index Futures Trading Lower Aug 03 2015
    Disney, Pfizer And 3 Other Stocks Positioned To Lead The Dow Higher Aug 03 2015
    The Zacks Analyst Blog Highlights: Pfizer, DuPont, Procter & Gamble and Hospira - Press Releases Aug 03 2015
    Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of... Aug 03 2015
    8:32 am Pfizer acquires the exclusive commercialization rights in the United States to glatiramer... Aug 03 2015
    Pfizer and Synthon Enter Into U.S. Commercialization Agreement for Potential Generic Treatment of... Aug 03 2015
    Citing hacking risk, FDA says Hospira pump shouldn't be used Jul 31 2015
    FDA says hospitals should stop using Hospira pump Jul 31 2015
    FDA says hospitals should stop using Hospira pump Jul 31 2015
    Top Drug Stock Pfizer In Buy Area After Earnings Beat Jul 31 2015
    Your first trade for Monday Jul 31 2015
    Fast Money Final Trade: XOM, Z, GDX & PFE Jul 31 2015
    PFIZER INC Financials Jul 31 2015
    Roche drug maker probed in Romanian graft case Jul 31 2015
    Roche drug maker probed in Romanian graft case Jul 31 2015

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    SEENSCO
    ReplySEENSCO - 1 year ago
    PFE is trading at the low end of our short-term valuation range ($29-$36) and significantly below our Fair Value estimate of $42.41.
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    FEEDBACK